Skip to main content
Fig. 6 | Critical Care

Fig. 6

From: Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis

Fig. 6

Clustered ranking plot based on surface under the cumulative ranking curve (SUCRA). The plot shows SUCRA values of twelve antimicrobial treatments, commonly included in the analyses of the following outcomes: all-cause mortality, clinical cure, and microbiological eradication. A treatment lying in the farther-right upper corner is more effective in both all-cause mortality and clinical cure than other treatments. In addition, the larger bubble size reflects the greater SUCRA value in terms of microbiological eradication. Abbreviations: CAR carbapenem (imipenem or meropenem), COL colistin, FOS fosfomycin, GLY glycopeptide (vancomycin or teicoplanin), HD high-dose, IH inhaled, IV intravenous, RIF rifampin, SUL sulbactam, TIG tigecycline

Back to article page

Critical Care

ISSN: 1364-8535